Zimbabwe has turned down a substantial US health deal worth $367m (272 million pounds) spanning five years because of the United States' insistence on sensitive information.
The decision was revealed after a internal memorandum dated December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".
A government spokesperson has since clarified that the United States was requesting genetic material for scientific study and profit but was not willing to share the resulting advantages from future vaccines.
"We will now turn to the difficult and regrettable process of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had furnished over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has urged more talks to reach a agreement acceptable to all parties so the nation's critical HIV programme can continue.
Wider Context
This rejection comes after a comparable case in neighbouring Kenya, where a court suspended a similar deal with the US following legal challenges were filed about the safety of citizens' medical information.
Since resuming office recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
USAID had administered aid for the US government, but Trump argued its spending was "wasteful" and his government was seeking government-to-government agreements to boost transparency and responsibility.
Based on statements, Sixteen nations in Africa have so far agreed to similar agreements, constituting more than $18.3bn of fresh investment.
Details of the Declined Deal
The funds for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership would have delivered extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on HIV treatment through US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, with no corresponding guarantee of benefiting from any medical innovations – such as new medicines or tests – that might be developed from that provided information," his statement read.
"Put simply, our nation would provide the raw materials for medical research with no assurance that the resulting innovations would be available to our people should a new health crisis emerge."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting frameworks already established through the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to deal with future global health emergencies.
"This system is designed to guarantee that when a country contributes its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to develop them."
The government's concerns over the US deal "must not be interpreted as opposition to America," he added.
"We are open to further dialogue with our US partners on how future co-operation could be structured in a way that honours the independence and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but recommended that talks should continue considering much of the nation's Aids initiatives were funded by foreign aid.
"Where specific concerns exist, such as those relating to information security or agreement terms, these can often be addressed via technical clarification and negotiated safeguards," it commented.
The situation underscores the complex challenges between receiving crucial foreign assistance and safeguarding national sovereignty in an increasingly data-driven world.